Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
IKZF1
|
ENSG00000185811.12 | IKZF1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
IKZF1 | hg19_v2_chr7_+_50348268_50348366 | 0.80 | 1.8e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_35247859 | 5.09 |
ENST00000373362.3 |
GJB3 |
gap junction protein, beta 3, 31kDa |
chr19_-_51456344 | 4.30 |
ENST00000336334.3 ENST00000593428.1 |
KLK5 |
kallikrein-related peptidase 5 |
chr19_-_51456198 | 4.24 |
ENST00000594846.1 |
KLK5 |
kallikrein-related peptidase 5 |
chr19_-_51456321 | 4.23 |
ENST00000391809.2 |
KLK5 |
kallikrein-related peptidase 5 |
chr19_-_36004543 | 3.59 |
ENST00000339686.3 ENST00000447113.2 ENST00000440396.1 |
DMKN |
dermokine |
chr19_-_51487282 | 3.06 |
ENST00000595820.1 ENST00000597707.1 ENST00000336317.4 |
KLK7 |
kallikrein-related peptidase 7 |
chr16_+_68679193 | 3.05 |
ENST00000581171.1 |
CDH3 |
cadherin 3, type 1, P-cadherin (placental) |
chr1_+_209602609 | 2.97 |
ENST00000458250.1 |
MIR205HG |
MIR205 host gene (non-protein coding) |
chr18_-_47376197 | 2.79 |
ENST00000592688.1 |
MYO5B |
myosin VB |
chr8_+_95653373 | 2.78 |
ENST00000358397.5 |
ESRP1 |
epithelial splicing regulatory protein 1 |
chr16_-_31147020 | 2.61 |
ENST00000568261.1 ENST00000567797.1 ENST00000317508.6 |
PRSS8 |
protease, serine, 8 |
chr12_-_52845910 | 2.56 |
ENST00000252252.3 |
KRT6B |
keratin 6B |
chr11_+_130029457 | 2.55 |
ENST00000278742.5 |
ST14 |
suppression of tumorigenicity 14 (colon carcinoma) |
chr19_-_16045619 | 2.50 |
ENST00000402119.4 |
CYP4F11 |
cytochrome P450, family 4, subfamily F, polypeptide 11 |
chr12_-_8814669 | 2.44 |
ENST00000535411.1 ENST00000540087.1 |
MFAP5 |
microfibrillar associated protein 5 |
chr4_-_53617566 | 2.36 |
ENST00000440542.1 |
ERVMER34-1 |
endogenous retrovirus group MER34, member 1 |
chr18_+_21452804 | 2.33 |
ENST00000269217.6 |
LAMA3 |
laminin, alpha 3 |
chr12_-_51785182 | 2.33 |
ENST00000356317.3 ENST00000603188.1 ENST00000604847.1 ENST00000604506.1 |
GALNT6 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) |
chr19_-_16045665 | 2.29 |
ENST00000248041.8 |
CYP4F11 |
cytochrome P450, family 4, subfamily F, polypeptide 11 |
chr17_+_48610074 | 2.28 |
ENST00000503690.1 ENST00000514874.1 ENST00000537145.1 ENST00000541226.1 |
EPN3 |
epsin 3 |
chr1_+_44401479 | 2.26 |
ENST00000438616.3 |
ARTN |
artemin |
chr18_+_21452964 | 2.23 |
ENST00000587184.1 |
LAMA3 |
laminin, alpha 3 |
chr19_-_51522955 | 2.20 |
ENST00000358789.3 |
KLK10 |
kallikrein-related peptidase 10 |
chr8_+_95653302 | 2.18 |
ENST00000423620.2 ENST00000433389.2 |
ESRP1 |
epithelial splicing regulatory protein 1 |
chr19_+_17905919 | 2.13 |
ENST00000318683.6 ENST00000600777.1 ENST00000595387.1 |
B3GNT3 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
chr1_+_209602156 | 2.13 |
ENST00000429156.1 ENST00000366437.3 ENST00000603283.1 ENST00000431096.1 |
MIR205HG |
MIR205 host gene (non-protein coding) |
chr5_+_52776449 | 2.04 |
ENST00000396947.3 |
FST |
follistatin |
chr19_+_35609380 | 2.02 |
ENST00000604621.1 |
FXYD3 |
FXYD domain containing ion transport regulator 3 |
chr17_+_48609903 | 1.98 |
ENST00000268933.3 |
EPN3 |
epsin 3 |
chr19_-_55660561 | 1.97 |
ENST00000587758.1 ENST00000356783.5 ENST00000291901.8 ENST00000588426.1 ENST00000588147.1 ENST00000536926.1 ENST00000588981.1 |
TNNT1 |
troponin T type 1 (skeletal, slow) |
chr4_-_15939963 | 1.97 |
ENST00000259988.2 |
FGFBP1 |
fibroblast growth factor binding protein 1 |
chr17_-_7493390 | 1.96 |
ENST00000538513.2 ENST00000570788.1 ENST00000250055.2 |
SOX15 |
SRY (sex determining region Y)-box 15 |
chr1_+_153004800 | 1.95 |
ENST00000392661.3 |
SPRR1B |
small proline-rich protein 1B |
chr10_-_135090338 | 1.94 |
ENST00000415217.3 |
ADAM8 |
ADAM metallopeptidase domain 8 |
chr14_-_105635090 | 1.93 |
ENST00000331782.3 ENST00000347004.2 |
JAG2 |
jagged 2 |
chr11_+_10476851 | 1.88 |
ENST00000396553.2 |
AMPD3 |
adenosine monophosphate deaminase 3 |
chr19_-_54676846 | 1.86 |
ENST00000301187.4 |
TMC4 |
transmembrane channel-like 4 |
chr1_+_15479021 | 1.83 |
ENST00000428417.1 |
TMEM51 |
transmembrane protein 51 |
chr19_+_35606692 | 1.81 |
ENST00000406242.3 ENST00000454903.2 |
FXYD3 |
FXYD domain containing ion transport regulator 3 |
chr11_+_69931519 | 1.80 |
ENST00000316296.5 ENST00000530676.1 |
ANO1 |
anoctamin 1, calcium activated chloride channel |
chr10_+_118187379 | 1.80 |
ENST00000369230.3 |
PNLIPRP3 |
pancreatic lipase-related protein 3 |
chr19_-_16045220 | 1.79 |
ENST00000326742.8 |
CYP4F11 |
cytochrome P450, family 4, subfamily F, polypeptide 11 |
chr18_+_61420169 | 1.79 |
ENST00000425392.1 ENST00000336429.2 |
SERPINB7 |
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
chr13_+_37006398 | 1.76 |
ENST00000418263.1 |
CCNA1 |
cyclin A1 |
chr1_-_209979465 | 1.76 |
ENST00000542854.1 |
IRF6 |
interferon regulatory factor 6 |
chr18_+_61554932 | 1.74 |
ENST00000299502.4 ENST00000457692.1 ENST00000413956.1 |
SERPINB2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
chr19_-_55653259 | 1.73 |
ENST00000593194.1 |
TNNT1 |
troponin T type 1 (skeletal, slow) |
chr1_-_209979375 | 1.71 |
ENST00000367021.3 |
IRF6 |
interferon regulatory factor 6 |
chr12_-_8815299 | 1.71 |
ENST00000535336.1 |
MFAP5 |
microfibrillar associated protein 5 |
chr15_+_40532058 | 1.66 |
ENST00000260404.4 |
PAK6 |
p21 protein (Cdc42/Rac)-activated kinase 6 |
chr17_-_7167279 | 1.64 |
ENST00000571932.2 |
CLDN7 |
claudin 7 |
chr16_+_4845379 | 1.64 |
ENST00000588606.1 ENST00000586005.1 |
SMIM22 |
small integral membrane protein 22 |
chr6_+_36097992 | 1.64 |
ENST00000211287.4 |
MAPK13 |
mitogen-activated protein kinase 13 |
chr8_+_124194875 | 1.63 |
ENST00000522648.1 ENST00000276699.6 |
FAM83A |
family with sequence similarity 83, member A |
chr16_+_3115378 | 1.61 |
ENST00000529550.1 ENST00000551122.1 ENST00000525643.2 ENST00000548807.1 ENST00000528163.2 |
IL32 |
interleukin 32 |
chr16_+_3014217 | 1.60 |
ENST00000572045.1 |
KREMEN2 |
kringle containing transmembrane protein 2 |
chr12_+_53342625 | 1.59 |
ENST00000388837.2 ENST00000550600.1 ENST00000388835.3 |
KRT18 |
keratin 18 |
chr20_+_58179582 | 1.55 |
ENST00000371015.1 ENST00000395639.4 |
PHACTR3 |
phosphatase and actin regulator 3 |
chr8_+_124194752 | 1.55 |
ENST00000318462.6 |
FAM83A |
family with sequence similarity 83, member A |
chr6_+_30850697 | 1.54 |
ENST00000509639.1 ENST00000412274.2 ENST00000507901.1 ENST00000507046.1 ENST00000437124.2 ENST00000454612.2 ENST00000396342.2 |
DDR1 |
discoidin domain receptor tyrosine kinase 1 |
chr20_+_44637526 | 1.53 |
ENST00000372330.3 |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr19_-_10697895 | 1.52 |
ENST00000591240.1 ENST00000589684.1 ENST00000591676.1 ENST00000250244.6 ENST00000590923.1 |
AP1M2 |
adaptor-related protein complex 1, mu 2 subunit |
chr1_+_234349957 | 1.51 |
ENST00000366617.3 |
SLC35F3 |
solute carrier family 35, member F3 |
chr19_-_54676884 | 1.51 |
ENST00000376591.4 |
TMC4 |
transmembrane channel-like 4 |
chr11_+_12308447 | 1.50 |
ENST00000256186.2 |
MICALCL |
MICAL C-terminal like |
chr2_+_17721920 | 1.49 |
ENST00000295156.4 |
VSNL1 |
visinin-like 1 |
chr19_+_45844018 | 1.49 |
ENST00000585434.1 |
KLC3 |
kinesin light chain 3 |
chr11_-_118122996 | 1.46 |
ENST00000525386.1 ENST00000527472.1 ENST00000278949.4 |
MPZL3 |
myelin protein zero-like 3 |
chr19_-_36001286 | 1.46 |
ENST00000602679.1 ENST00000492341.2 ENST00000472252.2 ENST00000602781.1 ENST00000402589.2 ENST00000458071.1 ENST00000436012.1 ENST00000443640.1 ENST00000450261.1 ENST00000467637.1 ENST00000480502.1 ENST00000474928.1 ENST00000414866.2 ENST00000392206.2 ENST00000488892.1 |
DMKN |
dermokine |
chr19_+_751122 | 1.45 |
ENST00000215582.6 |
MISP |
mitotic spindle positioning |
chr20_-_18038521 | 1.45 |
ENST00000278780.6 |
OVOL2 |
ovo-like zinc finger 2 |
chr1_+_153003671 | 1.44 |
ENST00000307098.4 |
SPRR1B |
small proline-rich protein 1B |
chr11_-_88070896 | 1.42 |
ENST00000529974.1 ENST00000527018.1 |
CTSC |
cathepsin C |
chr1_+_15479054 | 1.42 |
ENST00000376014.3 ENST00000451326.2 |
TMEM51 |
transmembrane protein 51 |
chr6_+_36098262 | 1.41 |
ENST00000373761.6 ENST00000373766.5 |
MAPK13 |
mitogen-activated protein kinase 13 |
chr6_+_30848557 | 1.41 |
ENST00000460944.2 ENST00000324771.8 |
DDR1 |
discoidin domain receptor tyrosine kinase 1 |
chr17_-_3595181 | 1.40 |
ENST00000552050.1 |
P2RX5 |
purinergic receptor P2X, ligand-gated ion channel, 5 |
chr10_-_45474237 | 1.40 |
ENST00000448778.1 ENST00000298295.3 |
C10orf10 |
chromosome 10 open reading frame 10 |
chr1_+_156030937 | 1.39 |
ENST00000361084.5 |
RAB25 |
RAB25, member RAS oncogene family |
chr3_-_46735155 | 1.38 |
ENST00000318962.4 |
ALS2CL |
ALS2 C-terminal like |
chr3_-_111314230 | 1.37 |
ENST00000317012.4 |
ZBED2 |
zinc finger, BED-type containing 2 |
chr3_-_49941042 | 1.36 |
ENST00000344206.4 ENST00000296474.3 |
MST1R |
macrophage stimulating 1 receptor (c-met-related tyrosine kinase) |
chr19_-_49258606 | 1.36 |
ENST00000310160.3 |
FUT1 |
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group) |
chr19_-_35992780 | 1.36 |
ENST00000593342.1 ENST00000601650.1 ENST00000408915.2 |
DMKN |
dermokine |
chr6_+_150464155 | 1.35 |
ENST00000361131.4 |
PPP1R14C |
protein phosphatase 1, regulatory (inhibitor) subunit 14C |
chr16_+_3115323 | 1.34 |
ENST00000531965.1 ENST00000396887.3 ENST00000529699.1 ENST00000526464.2 ENST00000440815.3 |
IL32 |
interleukin 32 |
chr19_+_35606777 | 1.34 |
ENST00000604404.1 ENST00000435734.2 ENST00000603181.1 |
FXYD3 |
FXYD domain containing ion transport regulator 3 |
chr1_-_209824643 | 1.33 |
ENST00000391911.1 ENST00000415782.1 |
LAMB3 |
laminin, beta 3 |
chr19_-_51504411 | 1.32 |
ENST00000593490.1 |
KLK8 |
kallikrein-related peptidase 8 |
chr7_-_98030360 | 1.32 |
ENST00000005260.8 |
BAIAP2L1 |
BAI1-associated protein 2-like 1 |
chr19_-_55658687 | 1.31 |
ENST00000593046.1 |
TNNT1 |
troponin T type 1 (skeletal, slow) |
chr8_+_95653427 | 1.31 |
ENST00000454170.2 |
ESRP1 |
epithelial splicing regulatory protein 1 |
chr17_-_3599696 | 1.31 |
ENST00000225328.5 |
P2RX5 |
purinergic receptor P2X, ligand-gated ion channel, 5 |
chr4_+_106816592 | 1.29 |
ENST00000379987.2 ENST00000453617.2 ENST00000427316.2 ENST00000514622.1 ENST00000305572.8 |
NPNT |
nephronectin |
chr2_-_70781087 | 1.29 |
ENST00000394241.3 ENST00000295400.6 |
TGFA |
transforming growth factor, alpha |
chr1_+_2004901 | 1.29 |
ENST00000400921.2 |
PRKCZ |
protein kinase C, zeta |
chr6_+_28048753 | 1.29 |
ENST00000377325.1 |
ZNF165 |
zinc finger protein 165 |
chr19_+_35739631 | 1.29 |
ENST00000602003.1 ENST00000360798.3 ENST00000354900.3 |
LSR |
lipolysis stimulated lipoprotein receptor |
chr19_-_15090488 | 1.28 |
ENST00000594383.1 ENST00000598504.1 ENST00000597262.1 |
SLC1A6 |
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 |
chr11_-_88070920 | 1.28 |
ENST00000524463.1 ENST00000227266.5 |
CTSC |
cathepsin C |
chr4_-_53617798 | 1.28 |
ENST00000443173.1 |
ERVMER34-1 |
endogenous retrovirus group MER34, member 1 |
chr19_-_51487071 | 1.27 |
ENST00000391807.1 ENST00000593904.1 |
KLK7 |
kallikrein-related peptidase 7 |
chr19_-_6720686 | 1.27 |
ENST00000245907.6 |
C3 |
complement component 3 |
chr8_-_494824 | 1.26 |
ENST00000427263.2 ENST00000324079.6 |
TDRP |
testis development related protein |
chr7_-_143105941 | 1.26 |
ENST00000275815.3 |
EPHA1 |
EPH receptor A1 |
chr19_+_35607166 | 1.26 |
ENST00000604255.1 ENST00000346446.5 ENST00000344013.6 ENST00000603449.1 ENST00000406988.1 ENST00000605550.1 ENST00000604804.1 ENST00000605552.1 |
FXYD3 |
FXYD domain containing ion transport regulator 3 |
chr1_-_209825674 | 1.26 |
ENST00000367030.3 ENST00000356082.4 |
LAMB3 |
laminin, beta 3 |
chr19_-_55658281 | 1.26 |
ENST00000585321.2 ENST00000587465.2 |
TNNT1 |
troponin T type 1 (skeletal, slow) |
chr16_+_68678892 | 1.26 |
ENST00000429102.2 |
CDH3 |
cadherin 3, type 1, P-cadherin (placental) |
chr18_+_47088401 | 1.24 |
ENST00000261292.4 ENST00000427224.2 ENST00000580036.1 |
LIPG |
lipase, endothelial |
chr19_-_6690723 | 1.24 |
ENST00000601008.1 |
C3 |
complement component 3 |
chr2_+_69001913 | 1.24 |
ENST00000409030.3 ENST00000409220.1 |
ARHGAP25 |
Rho GTPase activating protein 25 |
chr19_-_49567124 | 1.23 |
ENST00000301411.3 |
NTF4 |
neurotrophin 4 |
chr13_+_37006421 | 1.22 |
ENST00000255465.4 |
CCNA1 |
cyclin A1 |
chr1_-_159915386 | 1.22 |
ENST00000361509.3 ENST00000368094.1 |
IGSF9 |
immunoglobulin superfamily, member 9 |
chr16_+_22825475 | 1.21 |
ENST00000261374.3 |
HS3ST2 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
chr10_+_47746929 | 1.21 |
ENST00000340243.6 ENST00000374277.5 ENST00000449464.2 ENST00000538825.1 ENST00000335083.5 |
ANXA8L2 AL603965.1 |
annexin A8-like 2 Protein LOC100996760 |
chr20_-_43883197 | 1.21 |
ENST00000338380.2 |
SLPI |
secretory leukocyte peptidase inhibitor |
chr10_-_135090360 | 1.20 |
ENST00000486609.1 ENST00000445355.3 ENST00000485491.2 |
ADAM8 |
ADAM metallopeptidase domain 8 |
chr12_+_41086297 | 1.20 |
ENST00000551295.2 |
CNTN1 |
contactin 1 |
chr19_+_35739597 | 1.19 |
ENST00000361790.3 |
LSR |
lipolysis stimulated lipoprotein receptor |
chr14_+_61788429 | 1.19 |
ENST00000332981.5 |
PRKCH |
protein kinase C, eta |
chr17_-_7166500 | 1.19 |
ENST00000575313.1 ENST00000397317.4 |
CLDN7 |
claudin 7 |
chr1_-_175162048 | 1.19 |
ENST00000444639.1 |
KIAA0040 |
KIAA0040 |
chr9_+_132096166 | 1.18 |
ENST00000436710.1 |
RP11-65J3.1 |
RP11-65J3.1 |
chr6_+_27215494 | 1.18 |
ENST00000230582.3 |
PRSS16 |
protease, serine, 16 (thymus) |
chr16_-_68269971 | 1.18 |
ENST00000565858.1 |
ESRP2 |
epithelial splicing regulatory protein 2 |
chr19_-_6767431 | 1.18 |
ENST00000437152.3 ENST00000597687.1 |
SH2D3A |
SH2 domain containing 3A |
chr12_-_6484715 | 1.18 |
ENST00000228916.2 |
SCNN1A |
sodium channel, non-voltage-gated 1 alpha subunit |
chr1_-_183559693 | 1.18 |
ENST00000367535.3 ENST00000413720.1 ENST00000418089.1 |
NCF2 |
neutrophil cytosolic factor 2 |
chr5_-_141257954 | 1.17 |
ENST00000456271.1 ENST00000394536.3 ENST00000503492.1 ENST00000287008.3 |
PCDH1 |
protocadherin 1 |
chr16_+_68678739 | 1.17 |
ENST00000264012.4 |
CDH3 |
cadherin 3, type 1, P-cadherin (placental) |
chr17_-_3599492 | 1.17 |
ENST00000435558.1 ENST00000345901.3 |
P2RX5 |
purinergic receptor P2X, ligand-gated ion channel, 5 |
chr1_-_28503693 | 1.16 |
ENST00000373857.3 |
PTAFR |
platelet-activating factor receptor |
chr19_+_35739897 | 1.16 |
ENST00000605618.1 ENST00000427250.1 ENST00000601623.1 |
LSR |
lipolysis stimulated lipoprotein receptor |
chr15_-_68497657 | 1.16 |
ENST00000448060.2 ENST00000467889.1 |
CALML4 |
calmodulin-like 4 |
chr1_+_153330322 | 1.16 |
ENST00000368738.3 |
S100A9 |
S100 calcium binding protein A9 |
chr19_+_35739280 | 1.15 |
ENST00000602122.1 |
LSR |
lipolysis stimulated lipoprotein receptor |
chr9_+_132099158 | 1.14 |
ENST00000444125.1 |
RP11-65J3.1 |
RP11-65J3.1 |
chr1_+_2036149 | 1.14 |
ENST00000482686.1 ENST00000400920.1 ENST00000486681.1 |
PRKCZ |
protein kinase C, zeta |
chr12_-_8815215 | 1.14 |
ENST00000544889.1 ENST00000543369.1 |
MFAP5 |
microfibrillar associated protein 5 |
chr3_+_111717511 | 1.14 |
ENST00000478951.1 ENST00000393917.2 |
TAGLN3 |
transgelin 3 |
chr2_+_17721230 | 1.14 |
ENST00000457525.1 |
VSNL1 |
visinin-like 1 |
chr19_+_45312347 | 1.13 |
ENST00000270233.6 ENST00000591520.1 |
BCAM |
basal cell adhesion molecule (Lutheran blood group) |
chr1_-_12677714 | 1.13 |
ENST00000376223.2 |
DHRS3 |
dehydrogenase/reductase (SDR family) member 3 |
chr11_-_125366089 | 1.12 |
ENST00000366139.3 ENST00000278919.3 |
FEZ1 |
fasciculation and elongation protein zeta 1 (zygin I) |
chr18_+_21529811 | 1.12 |
ENST00000588004.1 |
LAMA3 |
laminin, alpha 3 |
chr4_+_100737954 | 1.12 |
ENST00000296414.7 ENST00000512369.1 |
DAPP1 |
dual adaptor of phosphotyrosine and 3-phosphoinositides |
chr2_-_235405679 | 1.12 |
ENST00000390645.2 |
ARL4C |
ADP-ribosylation factor-like 4C |
chr16_+_71660079 | 1.11 |
ENST00000565261.1 ENST00000268485.3 ENST00000299952.4 |
MARVELD3 |
MARVEL domain containing 3 |
chr10_-_10836919 | 1.11 |
ENST00000602763.1 ENST00000415590.2 ENST00000434919.2 |
SFTA1P |
surfactant associated 1, pseudogene |
chr16_-_85784557 | 1.11 |
ENST00000602675.1 |
C16orf74 |
chromosome 16 open reading frame 74 |
chr2_+_102608306 | 1.11 |
ENST00000332549.3 |
IL1R2 |
interleukin 1 receptor, type II |
chr2_-_70780770 | 1.11 |
ENST00000444975.1 ENST00000445399.1 ENST00000418333.2 |
TGFA |
transforming growth factor, alpha |
chr8_-_41166953 | 1.11 |
ENST00000220772.3 |
SFRP1 |
secreted frizzled-related protein 1 |
chr6_-_47010061 | 1.11 |
ENST00000371253.2 |
GPR110 |
G protein-coupled receptor 110 |
chr1_+_35220613 | 1.10 |
ENST00000338513.1 |
GJB5 |
gap junction protein, beta 5, 31.1kDa |
chr16_+_57662419 | 1.10 |
ENST00000388812.4 ENST00000538815.1 ENST00000456916.1 ENST00000567154.1 ENST00000388813.5 ENST00000562558.1 ENST00000566271.2 |
GPR56 |
G protein-coupled receptor 56 |
chr10_-_54215029 | 1.09 |
ENST00000435813.2 |
RP11-346D6.6 |
RP11-346D6.6 |
chr12_-_52911718 | 1.09 |
ENST00000548409.1 |
KRT5 |
keratin 5 |
chr5_+_140227048 | 1.09 |
ENST00000532602.1 |
PCDHA9 |
protocadherin alpha 9 |
chr22_-_43583079 | 1.08 |
ENST00000216129.6 |
TTLL12 |
tubulin tyrosine ligase-like family, member 12 |
chr11_+_60691924 | 1.08 |
ENST00000544065.1 ENST00000453848.2 ENST00000005286.4 |
TMEM132A |
transmembrane protein 132A |
chr3_-_69435224 | 1.08 |
ENST00000398540.3 |
FRMD4B |
FERM domain containing 4B |
chr11_+_62648336 | 1.07 |
ENST00000338663.7 |
SLC3A2 |
solute carrier family 3 (amino acid transporter heavy chain), member 2 |
chr15_-_79237433 | 1.07 |
ENST00000220166.5 |
CTSH |
cathepsin H |
chr19_-_6767516 | 1.07 |
ENST00000245908.6 |
SH2D3A |
SH2 domain containing 3A |
chr18_-_28622774 | 1.07 |
ENST00000434452.1 |
DSC3 |
desmocollin 3 |
chr9_-_139948487 | 1.07 |
ENST00000355097.2 |
ENTPD2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
chr11_+_1856034 | 1.07 |
ENST00000341958.3 |
SYT8 |
synaptotagmin VIII |
chr2_-_238499725 | 1.07 |
ENST00000264601.3 |
RAB17 |
RAB17, member RAS oncogene family |
chr16_+_3115298 | 1.07 |
ENST00000325568.5 ENST00000534507.1 |
IL32 |
interleukin 32 |
chr12_+_113376157 | 1.06 |
ENST00000228928.7 |
OAS3 |
2'-5'-oligoadenylate synthetase 3, 100kDa |
chr2_+_220492116 | 1.06 |
ENST00000373760.2 |
SLC4A3 |
solute carrier family 4 (anion exchanger), member 3 |
chr6_-_11779174 | 1.06 |
ENST00000379413.2 |
ADTRP |
androgen-dependent TFPI-regulating protein |
chr1_+_160370344 | 1.06 |
ENST00000368061.2 |
VANGL2 |
VANGL planar cell polarity protein 2 |
chr11_-_102668879 | 1.05 |
ENST00000315274.6 |
MMP1 |
matrix metallopeptidase 1 (interstitial collagenase) |
chr19_+_45843994 | 1.05 |
ENST00000391946.2 |
KLC3 |
kinesin light chain 3 |
chr10_-_90342947 | 1.04 |
ENST00000437752.1 ENST00000331772.4 |
RNLS |
renalase, FAD-dependent amine oxidase |
chr19_+_35739782 | 1.01 |
ENST00000347609.4 |
LSR |
lipolysis stimulated lipoprotein receptor |
chr17_-_77925806 | 1.01 |
ENST00000574241.2 |
TBC1D16 |
TBC1 domain family, member 16 |
chr11_-_119991589 | 1.01 |
ENST00000526881.1 |
TRIM29 |
tripartite motif containing 29 |
chr9_-_136004782 | 1.01 |
ENST00000393157.3 |
RALGDS |
ral guanine nucleotide dissociation stimulator |
chr1_-_153588334 | 1.00 |
ENST00000476873.1 |
S100A14 |
S100 calcium binding protein A14 |
chr12_-_8815404 | 1.00 |
ENST00000359478.2 ENST00000396549.2 |
MFAP5 |
microfibrillar associated protein 5 |
chr7_-_32111009 | 1.00 |
ENST00000396184.3 ENST00000396189.2 ENST00000321453.7 |
PDE1C |
phosphodiesterase 1C, calmodulin-dependent 70kDa |
chr11_-_119993979 | 0.99 |
ENST00000524816.3 ENST00000525327.1 |
TRIM29 |
tripartite motif containing 29 |
chr19_+_45844032 | 0.99 |
ENST00000589837.1 |
KLC3 |
kinesin light chain 3 |
chr11_+_10471836 | 0.99 |
ENST00000444303.2 |
AMPD3 |
adenosine monophosphate deaminase 3 |
chr11_-_79151695 | 0.99 |
ENST00000278550.7 |
TENM4 |
teneurin transmembrane protein 4 |
chr1_+_44399466 | 0.98 |
ENST00000498139.2 ENST00000491846.1 |
ARTN |
artemin |
chr16_+_68771128 | 0.98 |
ENST00000261769.5 ENST00000422392.2 |
CDH1 |
cadherin 1, type 1, E-cadherin (epithelial) |
chr12_-_28124903 | 0.98 |
ENST00000395872.1 ENST00000354417.3 ENST00000201015.4 |
PTHLH |
parathyroid hormone-like hormone |
chr7_+_86273700 | 0.98 |
ENST00000546348.1 |
GRM3 |
glutamate receptor, metabotropic 3 |
chrX_+_135618258 | 0.98 |
ENST00000440515.1 ENST00000456412.1 |
VGLL1 |
vestigial like 1 (Drosophila) |
chr12_-_54785054 | 0.97 |
ENST00000352268.6 ENST00000549962.1 |
ZNF385A |
zinc finger protein 385A |
chr1_+_3388181 | 0.97 |
ENST00000418137.1 ENST00000413250.2 |
ARHGEF16 |
Rho guanine nucleotide exchange factor (GEF) 16 |
chr11_-_87908600 | 0.97 |
ENST00000531138.1 ENST00000526372.1 ENST00000243662.6 |
RAB38 |
RAB38, member RAS oncogene family |
chr6_+_27215471 | 0.96 |
ENST00000421826.2 |
PRSS16 |
protease, serine, 16 (thymus) |
chr9_+_35673853 | 0.96 |
ENST00000378357.4 |
CA9 |
carbonic anhydrase IX |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 17.2 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
1.8 | 5.5 | GO:0060901 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
1.7 | 6.8 | GO:0042377 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
1.2 | 5.8 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
1.1 | 6.4 | GO:1903575 | cornified envelope assembly(GO:1903575) |
1.0 | 3.1 | GO:2000309 | activation of MAPK activity involved in innate immune response(GO:0035419) positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
0.9 | 2.8 | GO:1904303 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.9 | 4.5 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.9 | 7.9 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.8 | 2.5 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.8 | 2.3 | GO:0048627 | myoblast development(GO:0048627) |
0.8 | 3.8 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.7 | 2.8 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.6 | 0.6 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.6 | 2.5 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.6 | 1.8 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.6 | 2.3 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.6 | 1.7 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.5 | 1.6 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
0.5 | 2.1 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
0.5 | 2.6 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.5 | 3.1 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.5 | 2.5 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.5 | 2.3 | GO:0060356 | leucine import(GO:0060356) |
0.5 | 2.3 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
0.5 | 0.5 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.4 | 13.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 2.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 3.1 | GO:0070778 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
0.4 | 1.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.4 | 0.4 | GO:0097490 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.4 | 1.6 | GO:0002238 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
0.4 | 1.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.4 | 0.4 | GO:0002347 | response to tumor cell(GO:0002347) |
0.4 | 0.8 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
0.4 | 3.9 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.4 | 2.7 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.4 | 1.2 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.4 | 1.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.4 | 1.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 1.5 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.4 | 3.4 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.4 | 1.9 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 1.5 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.4 | 1.4 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.4 | 2.5 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.4 | 1.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.3 | 1.0 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.3 | 1.0 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.3 | 0.7 | GO:1990523 | bone regeneration(GO:1990523) |
0.3 | 2.7 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 2.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.3 | 1.0 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.3 | 0.7 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.3 | 1.3 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.3 | 1.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.3 | 1.0 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.3 | 0.3 | GO:0007051 | spindle organization(GO:0007051) |
0.3 | 3.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 4.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.3 | 1.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.3 | 1.5 | GO:1990834 | response to odorant(GO:1990834) |
0.3 | 0.9 | GO:0071789 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.3 | 0.9 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 0.6 | GO:0032499 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) |
0.3 | 1.2 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.3 | 2.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 2.3 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.3 | 0.8 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.3 | 0.8 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.3 | 0.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 1.4 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.3 | 0.8 | GO:0097254 | renal tubular secretion(GO:0097254) |
0.3 | 0.8 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.3 | 1.6 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.3 | 1.1 | GO:0050976 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
0.3 | 1.1 | GO:0003134 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
0.3 | 0.8 | GO:1901207 | regulation of heart looping(GO:1901207) |
0.3 | 0.8 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.3 | 1.6 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.3 | 1.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 0.8 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.3 | 0.8 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.2 | 0.2 | GO:0045632 | negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of mechanoreceptor differentiation(GO:0045632) arterial endothelial cell fate commitment(GO:0060844) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
0.2 | 0.2 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.2 | 2.2 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.2 | 0.5 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.2 | 0.7 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
0.2 | 0.7 | GO:0015820 | leucine transport(GO:0015820) |
0.2 | 0.7 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.7 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.2 | 1.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 0.2 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.2 | 1.4 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.7 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.2 | 0.9 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.2 | 0.9 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.2 | 1.2 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.2 | 1.4 | GO:0060214 | endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.2 | 1.4 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.7 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.2 | 0.9 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.2 | 0.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 2.0 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.7 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.2 | 0.2 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
0.2 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.7 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.2 | 1.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 0.4 | GO:0009386 | translational attenuation(GO:0009386) |
0.2 | 2.8 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 0.6 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
0.2 | 1.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 0.6 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.2 | 2.5 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.6 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.2 | 0.8 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.8 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
0.2 | 1.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 0.2 | GO:0060067 | cervix development(GO:0060067) |
0.2 | 3.5 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.2 | 0.6 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
0.2 | 1.0 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.2 | 0.2 | GO:0014032 | neural crest cell development(GO:0014032) |
0.2 | 0.2 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 0.6 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.2 | 1.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 0.4 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) cellular response to angiotensin(GO:1904385) |
0.2 | 0.6 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.2 | 1.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 1.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 1.0 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.2 | 0.4 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.2 | 1.4 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.2 | 1.4 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.2 | 1.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 6.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.4 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.6 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.2 | 0.6 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.2 | 1.3 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 1.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 2.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.4 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.2 | 1.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 0.8 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.2 | 0.6 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.9 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.2 | 0.6 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 0.9 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.2 | 2.3 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 0.6 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.2 | 0.2 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.2 | 0.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.2 | 1.1 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.2 | 0.2 | GO:0090346 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.2 | 0.5 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.2 | 0.4 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 0.2 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.2 | 1.9 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.9 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.2 | 0.7 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.2 | 0.5 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.2 | 0.3 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.2 | 0.2 | GO:0060197 | cloacal septation(GO:0060197) |
0.2 | 0.7 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.2 | 1.2 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.2 | 5.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.3 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.2 | 1.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 1.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.2 | 0.5 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.2 | 0.8 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 1.3 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 0.3 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.2 | 20.4 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.5 | GO:1990641 | response to iron ion starvation(GO:1990641) |
0.2 | 0.3 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 1.1 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.2 | 0.3 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.2 | 0.3 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.2 | 0.5 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.2 | 0.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 0.5 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.2 | 0.2 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.2 | 0.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.3 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
0.2 | 0.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.4 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.1 | 0.3 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.1 | 0.4 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.1 | 1.2 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 1.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.7 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 1.9 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.1 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
0.1 | 0.4 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 0.4 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.1 | 0.3 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.1 | 0.4 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.1 | 0.3 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.1 | 0.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.6 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.1 | 0.4 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
0.1 | 1.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.4 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
0.1 | 5.8 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.1 | 0.4 | GO:1904596 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.1 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.4 | GO:1904800 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.1 | 0.4 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 1.0 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.1 | 1.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 1.5 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 1.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.4 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.1 | 0.4 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.1 | 0.3 | GO:1900673 | olefin metabolic process(GO:1900673) |
0.1 | 0.7 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 1.4 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 1.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 1.5 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.4 | GO:0015883 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
0.1 | 1.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 1.1 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.9 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 1.2 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 4.7 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.8 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.1 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.6 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.1 | 0.1 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.1 | 0.8 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.9 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.4 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
0.1 | 0.4 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.1 | 1.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 1.0 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 0.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.6 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 1.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.5 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.1 | 1.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.6 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.4 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.1 | 1.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.4 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.1 | 0.5 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 0.5 | GO:0009644 | response to high light intensity(GO:0009644) |
0.1 | 0.9 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.5 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.1 | 0.2 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.1 | 0.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.4 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.1 | 0.4 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.1 | 0.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.7 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.1 | 0.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.6 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.6 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 0.7 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.1 | 0.4 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 3.0 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 2.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.1 | GO:0051133 | regulation of NK T cell activation(GO:0051133) |
0.1 | 0.5 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.1 | 0.5 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.1 | 1.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.7 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.1 | 0.5 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.6 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.1 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.2 | GO:1904172 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
0.1 | 0.3 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.1 | 0.3 | GO:2000724 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.1 | 0.5 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.1 | 1.4 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 4.2 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 1.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 1.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 | 0.9 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 1.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.2 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
0.1 | 0.1 | GO:0051885 | positive regulation of anagen(GO:0051885) |
0.1 | 0.4 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.1 | 0.8 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 0.1 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.6 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.2 | GO:0006068 | ethanol metabolic process(GO:0006067) ethanol catabolic process(GO:0006068) |
0.1 | 0.3 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.1 | 0.2 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 1.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.7 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.1 | 0.3 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 0.2 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.2 | GO:0009798 | axis specification(GO:0009798) |
0.1 | 1.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.3 | GO:0048691 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.1 | 0.5 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 2.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.4 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.3 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.6 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.1 | 0.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.7 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.1 | 0.3 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.1 | 0.1 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.1 | 0.5 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.1 | 0.4 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.1 | 1.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.8 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.5 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.1 | 0.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.8 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.1 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.3 | GO:0050960 | detection of temperature stimulus involved in thermoception(GO:0050960) positive regulation of gastric acid secretion(GO:0060454) regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) response to capsazepine(GO:1901594) |
0.1 | 0.5 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.4 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.1 | 0.2 | GO:1900453 | negative regulation of long term synaptic depression(GO:1900453) |
0.1 | 0.2 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.1 | 0.2 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.1 | 0.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.1 | 0.2 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.1 | 0.7 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 0.4 | GO:0051958 | methotrexate transport(GO:0051958) |
0.1 | 0.6 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 2.2 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.2 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.3 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.1 | 0.7 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.1 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.5 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.1 | 0.3 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
0.1 | 0.1 | GO:1903179 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.1 | 0.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.2 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 0.5 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 0.5 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 0.6 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 1.0 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 0.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.1 | 0.7 | GO:1902915 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.3 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 0.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.7 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 1.1 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.3 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.1 | 0.3 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.4 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.1 | 0.3 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.1 | 0.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.7 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.1 | 0.7 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.5 | GO:1902661 | positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.1 | 0.2 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 0.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 4.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.4 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 0.1 | GO:1904884 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.1 | 0.5 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.1 | 0.4 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.1 | 0.2 | GO:1902617 | response to fluoride(GO:1902617) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.5 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.4 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.1 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.3 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.1 | 0.3 | GO:0009080 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.2 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.7 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.3 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.1 | 2.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.3 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.1 | 0.4 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.1 | 0.6 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 1.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.9 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.3 | GO:0003335 | corneocyte development(GO:0003335) |
0.1 | 1.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.3 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.1 | 0.1 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.1 | 0.2 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 | 6.5 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.3 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.1 | 0.1 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.1 | 0.2 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.1 | 0.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.1 | 2.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.1 | 0.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.1 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.5 | GO:0015744 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
0.1 | 0.4 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.1 | 0.2 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) regulation of rubidium ion transmembrane transporter activity(GO:2000686) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.1 | 0.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.2 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.1 | 0.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.2 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.1 | 0.6 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.2 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.1 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.2 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.1 | 0.7 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.3 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.1 | 0.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.2 | GO:1901535 | regulation of DNA demethylation(GO:1901535) |
0.1 | 0.6 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.1 | 0.5 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.1 | 0.1 | GO:0042311 | vasodilation(GO:0042311) |
0.1 | 0.2 | GO:0009111 | vitamin catabolic process(GO:0009111) |
0.1 | 0.2 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.2 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.2 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) |
0.1 | 0.2 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.1 | 0.4 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
0.1 | 1.9 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.1 | 0.5 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 0.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.4 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.7 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.2 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.1 | 0.3 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.1 | GO:0051464 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.1 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 0.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 1.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.1 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.1 | 0.4 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.1 | 0.1 | GO:0061217 | regulation of mesonephros development(GO:0061217) |
0.1 | 0.6 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.1 | 0.1 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.4 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 1.0 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.1 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.1 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.1 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.3 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.1 | 0.1 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.1 | 0.1 | GO:0036343 | psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
0.1 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.1 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.1 | 1.7 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 0.4 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.1 | 0.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.2 | GO:0021722 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.1 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.2 | GO:0072278 | metanephric comma-shaped body morphogenesis(GO:0072278) |
0.1 | 0.4 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 0.2 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.1 | 0.1 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
0.1 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.1 | 0.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.6 | GO:1902741 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.1 | 0.8 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.3 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 0.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.1 | 0.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.2 | GO:1900920 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
0.1 | 0.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.4 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 0.1 | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
0.1 | 0.1 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.1 | 0.1 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 0.6 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 0.5 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.1 | 0.2 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.1 | 0.5 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.1 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.1 | 0.4 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.1 | 0.5 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.1 | 0.2 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.1 | 0.5 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 1.1 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.1 | 0.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.3 | GO:1903412 | response to bile acid(GO:1903412) |
0.1 | 0.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 0.1 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.1 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.1 | 0.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.2 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.2 | GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 0.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.1 | 0.9 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 0.1 | GO:0003285 | septum secundum development(GO:0003285) |
0.1 | 0.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.6 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.1 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.3 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
0.1 | 0.8 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.1 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.1 | 0.1 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.1 | 0.1 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.1 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.3 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.1 | 0.2 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.1 | 0.1 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
0.1 | 0.1 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.1 | 0.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.2 | GO:0031247 | actin rod assembly(GO:0031247) |
0.1 | 0.4 | GO:0015811 | L-cystine transport(GO:0015811) |
0.1 | 0.1 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 0.2 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 0.8 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.9 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.1 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
0.1 | 0.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.1 | GO:1902230 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.3 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.1 | 0.2 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.1 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.9 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 1.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.2 | GO:0007538 | primary sex determination(GO:0007538) |
0.1 | 0.1 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.1 | 0.5 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.1 | 0.2 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.3 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.4 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.1 | 0.1 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
0.1 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.5 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.3 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.1 | 0.2 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.1 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.2 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 0.2 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.1 | 0.2 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
0.1 | 0.3 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.1 | 0.2 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) negative regulation of neuromuscular junction development(GO:1904397) |
0.1 | 0.1 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
0.1 | 1.4 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.1 | 1.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.1 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.1 | 0.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.1 | GO:1903311 | regulation of mRNA metabolic process(GO:1903311) |
0.1 | 0.1 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.1 | 0.1 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.2 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.1 | 3.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.2 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
0.1 | 0.4 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 1.1 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.1 | 0.2 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.5 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.1 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.1 | 0.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.3 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 1.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.1 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) regulation of potassium ion export across plasma membrane(GO:1903764) |
0.1 | 0.2 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
0.1 | 0.8 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.6 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 0.1 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.1 | 1.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.1 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.1 | 0.9 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.4 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.1 | 1.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.1 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 0.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.5 | GO:0045939 | negative regulation of steroid metabolic process(GO:0045939) |
0.1 | 0.3 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.1 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.1 | 0.3 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.1 | 0.1 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 0.4 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.3 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.4 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.3 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.1 | 0.1 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.1 | 0.1 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.1 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.7 | GO:1904871 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
0.1 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.4 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.2 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 0.3 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 0.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.2 | GO:0051412 | response to corticosterone(GO:0051412) |
0.1 | 0.9 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 1.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.1 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.1 | 0.8 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.7 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.3 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.1 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.0 | 0.2 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) positive regulation of alkaline phosphatase activity(GO:0010694) |
0.0 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.4 | GO:0042148 | strand invasion(GO:0042148) |
0.0 | 0.2 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.0 | 0.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.1 | GO:0018013 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.0 | 0.3 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.0 | 0.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.2 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.0 | 0.2 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.0 | 0.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.1 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.0 | 0.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.0 | 0.2 | GO:1903659 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) |
0.0 | 0.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0015872 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) dopamine transport(GO:0015872) |
0.0 | 0.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 1.1 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.4 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.2 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.0 | 0.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.0 | 0.0 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
0.0 | 0.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.1 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.0 | 0.0 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.0 | 0.0 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.0 | 0.5 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 | 0.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.1 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.0 | 0.2 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.4 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.8 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.0 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.0 | 0.3 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.0 | 0.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.7 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.1 | GO:0072579 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.0 | 0.5 | GO:0014870 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) |
0.0 | 0.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.0 | 0.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.8 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.1 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
0.0 | 0.0 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.0 | 0.2 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.0 | 0.1 | GO:0048690 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.0 | 0.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.0 | 0.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.1 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.0 | 0.1 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
0.0 | 0.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.4 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.0 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.9 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.0 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.0 | 0.2 | GO:0045575 | basophil activation(GO:0045575) |
0.0 | 0.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.0 | 0.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.2 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.0 | 0.3 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.0 | GO:1904640 | response to methionine(GO:1904640) |
0.0 | 0.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.0 | 0.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.0 | 0.1 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.0 | 0.4 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
0.0 | 0.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.0 | 0.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.1 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.1 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.2 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.3 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.4 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) regulation of serine-type peptidase activity(GO:1902571) |
0.0 | 0.2 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 1.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.4 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.0 | 0.2 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.0 | 0.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 1.6 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.2 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 1.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 1.5 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.4 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 0.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.0 | 0.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.2 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.0 | 0.0 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.0 | 0.5 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.0 | 0.0 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
0.0 | 0.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.0 | 0.1 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.0 | 0.0 | GO:0060992 | response to fungicide(GO:0060992) |
0.0 | 0.4 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.1 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.0 | 0.1 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.0 | 0.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 0.0 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.0 | 0.5 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.3 | GO:0021548 | pons development(GO:0021548) |
0.0 | 0.2 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.1 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.0 | 0.0 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.0 | 0.0 | GO:0060664 | androgen secretion(GO:0035935) epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.2 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.1 | GO:0061589 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.3 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.0 | 0.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.1 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.0 | 0.1 | GO:1901374 | acetate ester transport(GO:1901374) |
0.0 | 0.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.0 | 0.0 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.3 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.0 | 0.2 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.0 | 0.3 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.0 | 0.0 | GO:0034699 | response to luteinizing hormone(GO:0034699) |
0.0 | 0.0 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.0 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 1.2 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.3 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.1 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.0 | 0.1 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.0 | 0.2 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.0 | 0.2 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.2 | GO:0002396 | MHC protein complex assembly(GO:0002396) MHC class II protein complex assembly(GO:0002399) |
0.0 | 0.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.0 | 0.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.0 | 0.2 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.7 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.1 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
0.0 | 0.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 1.3 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.0 | 0.2 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.5 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.3 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.0 | 0.2 | GO:0097338 | response to clozapine(GO:0097338) |
0.0 | 0.1 | GO:0002001 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 5.5 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.2 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.0 | 0.0 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.0 | 0.0 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.0 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.0 | 0.0 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.0 | 0.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.1 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.0 | 0.1 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.0 | 0.1 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.0 | 0.0 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.0 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.5 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.0 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.0 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 0.6 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.0 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.0 | 0.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.0 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.1 | GO:0051665 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
0.0 | 0.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.1 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.0 | 0.0 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.0 | 0.2 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.0 | 0.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.0 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.0 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.0 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.0 | 0.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.7 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.1 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
0.0 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.1 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
0.0 | 0.1 | GO:0021779 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) immunoglobulin V(D)J recombination(GO:0033152) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.1 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.0 | 0.1 | GO:0009712 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.0 | 0.1 | GO:0014062 | regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
0.0 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.0 | GO:0070627 | ferrous iron import(GO:0070627) |
0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.3 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.0 | 0.4 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.0 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.4 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.5 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.0 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.0 | 0.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.4 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.1 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.1 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.0 | 0.1 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.0 | 0.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.1 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.0 | 0.1 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.0 | 0.0 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.1 | GO:0021997 | neural plate axis specification(GO:0021997) |
0.0 | 0.1 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.2 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.2 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.0 | 0.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.0 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.3 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.1 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
0.0 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.1 | GO:1904106 | protein localization to microvillus(GO:1904106) |
0.0 | 0.2 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.0 | 0.1 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
0.0 | 0.2 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.3 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 1.1 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.0 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.1 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) type B pancreatic cell maturation(GO:0072560) |
0.0 | 0.0 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.3 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.1 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.0 | 0.0 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.0 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.6 | GO:0071871 | response to epinephrine(GO:0071871) |
0.0 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.0 | 0.1 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.0 | 0.0 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.0 | 0.0 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.0 | 0.0 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.0 | 2.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.3 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.0 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.2 | GO:1901660 | calcium ion export(GO:1901660) |
0.0 | 0.0 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
0.0 | 0.1 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.0 | 3.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.3 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.0 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
0.0 | 0.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.0 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.1 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.0 | 0.0 | GO:0021772 | olfactory bulb development(GO:0021772) olfactory lobe development(GO:0021988) |
0.0 | 0.1 | GO:0072386 | plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.1 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.0 | 0.0 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.0 | 0.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.1 | GO:0044116 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.0 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.1 | GO:2000767 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.3 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.1 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.0 | 0.1 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.0 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.2 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.0 | 0.8 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.1 | GO:0046959 | habituation(GO:0046959) |
0.0 | 0.0 | GO:1900125 | regulation of hyaluronan biosynthetic process(GO:1900125) |
0.0 | 0.1 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.0 | 0.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.1 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.0 | 0.0 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.0 | 0.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.2 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) |
0.0 | 0.4 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.2 | GO:0010171 | body morphogenesis(GO:0010171) embryonic body morphogenesis(GO:0010172) |
0.0 | 0.0 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.2 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.1 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.0 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.2 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.0 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.3 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.0 | 0.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.0 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.0 | 0.1 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.0 | 0.2 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 1.5 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:1904667 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.0 | 0.0 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.0 | 0.3 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.0 | 0.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.5 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.1 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.0 | 0.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.2 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.5 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.0 | 0.1 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.0 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.1 | GO:0043335 | protein unfolding(GO:0043335) |
0.0 | 0.0 | GO:0072276 | bronchiole development(GO:0060435) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.0 | 0.0 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.1 | GO:1903568 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.1 | GO:1902363 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.0 | 0.1 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.3 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.0 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.3 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.0 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.0 | 0.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:1904073 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.0 | 0.1 | GO:0050893 | sensory processing(GO:0050893) |
0.0 | 0.0 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.0 | 0.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.0 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
0.0 | 0.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:0009213 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.0 | 0.3 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.0 | 0.1 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 0.1 | GO:0043368 | positive T cell selection(GO:0043368) |
0.0 | 0.4 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.0 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 1.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.0 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.2 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 0.7 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
0.0 | 0.1 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.0 | 0.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.1 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.0 | 0.0 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.0 | 0.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 0.0 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.0 | 0.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.3 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.2 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.0 | 0.2 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.0 | 0.1 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.0 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.1 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.0 | 0.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 0.0 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.2 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.0 | 0.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.0 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.0 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.1 | GO:1903788 | mycotoxin metabolic process(GO:0043385) mycotoxin catabolic process(GO:0043387) aflatoxin metabolic process(GO:0046222) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound metabolic process(GO:1901376) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.0 | 0.0 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.0 | 0.0 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.0 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.0 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.0 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.0 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.0 | 0.0 | GO:0051883 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.0 | 0.0 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 0.0 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.0 | 0.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.0 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.0 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.0 | 0.1 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.0 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.0 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.1 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.0 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.0 | 0.0 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.1 | GO:0007098 | centrosome cycle(GO:0007098) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.0 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.0 | 0.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.0 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.0 | 0.1 | GO:0045844 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.0 | 0.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.0 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.6 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.0 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:0043297 | apical junction assembly(GO:0043297) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.0 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.0 | 0.1 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.0 | 0.1 | GO:0003016 | respiratory system process(GO:0003016) |
0.0 | 0.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.1 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.1 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.0 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.0 | 0.0 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.0 | 0.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.0 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 0.3 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.0 | GO:0071352 | cellular response to interleukin-2(GO:0071352) |
0.0 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.0 | 0.1 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 1.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.0 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 17.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.0 | 8.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.0 | 3.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.9 | 3.6 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.8 | 3.9 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.7 | 6.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.5 | 11.1 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 5.8 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 8.1 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 1.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.3 | 0.9 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
0.3 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 9.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 1.7 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 1.3 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.2 | 0.7 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.2 | 0.7 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.2 | 2.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 1.0 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
0.2 | 0.7 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.2 | 2.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 13.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 0.7 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.2 | 1.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.2 | 3.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.4 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 1.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 1.0 | GO:0031905 | early endosome lumen(GO:0031905) |
0.2 | 0.9 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 1.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.2 | 0.7 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.2 | 1.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 1.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 0.7 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.2 | 0.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 4.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 0.5 | GO:1990032 | parallel fiber(GO:1990032) |
0.2 | 1.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 0.5 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.5 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.2 | 1.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 0.6 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.2 | 0.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 0.6 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.2 | 0.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 1.1 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 0.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 0.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 0.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.4 | GO:0016938 | kinesin I complex(GO:0016938) |
0.1 | 0.4 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.1 | 1.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 1.0 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 1.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.6 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.1 | 1.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.3 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.1 | 1.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 1.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 1.3 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 0.8 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 3.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.4 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.1 | 0.8 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 2.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.4 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.1 | 0.6 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 0.8 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 1.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.3 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.1 | 1.4 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.1 | 0.5 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.3 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.1 | 0.4 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 2.5 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 0.9 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 9.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 1.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 2.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 7.1 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.1 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.1 | 0.6 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.1 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 1.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 1.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.3 | GO:0001534 | radial spoke(GO:0001534) |
0.1 | 1.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.6 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.2 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.1 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.8 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 0.2 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.1 | 0.6 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 1.6 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.3 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.1 | 1.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 0.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 2.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
0.1 | 0.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.2 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.1 | 0.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.2 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 2.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.9 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 7.6 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 0.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.3 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.1 | 0.2 | GO:0019034 | viral replication complex(GO:0019034) |
0.1 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 1.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.3 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.2 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.1 | 0.3 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.5 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.1 | 1.5 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.1 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 2.5 | GO:0005903 | brush border(GO:0005903) |
0.1 | 5.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.6 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.3 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 1.0 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.3 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 1.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.2 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.1 | 0.2 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.1 | 0.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.1 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.1 | 0.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 1.7 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 4.0 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 0.2 | GO:0098855 | HCN channel complex(GO:0098855) |
0.1 | 0.1 | GO:0030135 | coated vesicle(GO:0030135) |
0.1 | 0.2 | GO:1990742 | microvesicle(GO:1990742) |
0.1 | 0.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.0 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.0 | 0.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.3 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.9 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 1.6 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.0 | 0.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.3 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.0 | 0.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.4 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.0 | 0.7 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.0 | 0.3 | GO:1990037 | Lewy body core(GO:1990037) |
0.0 | 1.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.3 | GO:1990752 | microtubule end(GO:1990752) |
0.0 | 1.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.8 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.0 | 0.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 1.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.2 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.4 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.1 | GO:0030849 | autosome(GO:0030849) |
0.0 | 0.2 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.0 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.0 | GO:0036019 | endolysosome(GO:0036019) |
0.0 | 5.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.0 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.1 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.0 | 0.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.4 | GO:0031906 | late endosome lumen(GO:0031906) |
0.0 | 0.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 1.1 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 1.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.0 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
0.0 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 2.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.2 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 9.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 2.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.9 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.0 | 0.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 1.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.1 | GO:0071746 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.6 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.1 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 1.5 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.0 | 0.1 | GO:0070985 | TFIIK complex(GO:0070985) |
0.0 | 0.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.1 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.8 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 0.1 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.6 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.0 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 2.0 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.1 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 3.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 1.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.9 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.0 | 0.8 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.4 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 1.0 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.0 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.2 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.8 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.0 | 0.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.0 | GO:0005652 | lamin filament(GO:0005638) nuclear lamina(GO:0005652) |
0.0 | 0.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.0 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.9 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.2 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.3 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.0 | GO:0097447 | dendritic tree(GO:0097447) |
0.0 | 0.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.0 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.0 | 0.1 | GO:0005713 | recombination nodule(GO:0005713) |
0.0 | 0.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.0 | 1.3 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 0.2 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 2.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.0 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.2 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.0 | 0.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 1.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.0 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 0.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.0 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 4.3 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.8 | 10.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.7 | 2.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.6 | 1.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.6 | 0.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.5 | 1.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.5 | 1.5 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.5 | 2.5 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.5 | 1.4 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.4 | 3.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.4 | 1.2 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 3.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 3.6 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 1.2 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.4 | 1.2 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.4 | 1.1 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.4 | 1.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 1.0 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.3 | 1.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 3.6 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 1.6 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.3 | 0.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 1.5 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.3 | 1.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 0.9 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.3 | 1.4 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.3 | 5.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 1.1 | GO:0030305 | heparanase activity(GO:0030305) |
0.3 | 0.8 | GO:0070362 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
0.3 | 0.3 | GO:0015216 | purine nucleotide transmembrane transporter activity(GO:0015216) |
0.3 | 1.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 1.4 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.3 | 0.8 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.3 | 1.3 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.3 | 5.9 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 1.9 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 1.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.3 | 2.4 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.3 | 0.8 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.3 | 0.8 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
0.3 | 0.8 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.3 | 2.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 0.8 | GO:0097259 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.2 | 4.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 3.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 1.0 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.2 | 6.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.2 | 1.5 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 1.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 0.7 | GO:0070283 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
0.2 | 1.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 2.3 | GO:0030883 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.2 | 0.9 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 3.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 1.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 0.4 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.2 | 1.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.8 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.2 | 1.0 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.2 | 1.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 1.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 0.6 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.2 | 1.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.8 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.2 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.6 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.2 | 0.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 0.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.4 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.2 | 0.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 1.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.9 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.2 | 0.5 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.2 | 1.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.9 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
0.2 | 1.0 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 11.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 1.2 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 0.7 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.2 | 0.7 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.2 | 0.5 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.2 | 1.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 1.3 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.2 | 0.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.2 | 5.2 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 0.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 0.6 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.2 | 1.0 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.2 | 2.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 2.9 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 0.6 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.2 | 0.8 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 2.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.6 | GO:0046979 | TAP2 binding(GO:0046979) |
0.2 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.2 | 0.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.2 | 0.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 2.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 0.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 0.5 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.2 | 0.5 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.2 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 1.5 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 2.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.6 | GO:0004672 | protein kinase activity(GO:0004672) |
0.1 | 1.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.4 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 0.4 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 0.4 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.1 | 0.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 1.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.8 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.1 | 0.8 | GO:0008940 | nitrate reductase activity(GO:0008940) |
0.1 | 0.4 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.1 | 0.4 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.1 | 0.4 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 0.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.5 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.4 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.1 | 0.1 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 0.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) D4 dopamine receptor binding(GO:0031751) |
0.1 | 3.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 5.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 1.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.9 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 1.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.4 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 0.5 | GO:0038025 | reelin receptor activity(GO:0038025) |
0.1 | 0.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 4.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 1.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.1 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 2.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.2 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.1 | 0.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.9 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.1 | 0.7 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.4 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.1 | 0.5 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.1 | 2.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.4 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.1 | 0.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.1 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 1.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 3.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.4 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.1 | 1.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.6 | GO:0015639 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.1 | 0.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 1.5 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.3 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.1 | 0.2 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.1 | 0.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.4 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 1.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 1.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 33.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 3.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.3 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 0.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 1.5 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 4.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.6 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.1 | 0.2 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.1 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 0.3 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.1 | 0.4 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.1 | 0.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.6 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.2 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.1 | 0.6 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.5 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 1.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.3 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.1 | 0.7 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 1.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 1.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.1 | GO:0032404 | mismatch repair complex binding(GO:0032404) MutLalpha complex binding(GO:0032405) |
0.1 | 1.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.1 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.1 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.1 | 0.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 2.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 1.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 2.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 1.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.3 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.1 | 0.9 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.2 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.1 | 0.3 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.1 | 0.3 | GO:0000035 | acyl binding(GO:0000035) |
0.1 | 0.1 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
0.1 | 1.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 2.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.2 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 4.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.2 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.1 | 0.6 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.3 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) |
0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.5 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 0.2 | GO:0045118 | thiamine transmembrane transporter activity(GO:0015234) azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.2 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.1 | 0.2 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.1 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 4.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 1.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 2.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.9 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 2.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.7 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.9 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 1.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 1.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.9 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.1 | 1.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 1.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 1.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.6 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.1 | 0.4 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.1 | 0.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.3 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 0.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 2.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.1 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.1 | 1.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.2 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.1 | 0.3 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.1 | 0.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.3 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.1 | 0.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.1 | 1.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.2 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 0.3 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 0.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 1.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 1.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 1.1 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.1 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.2 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.1 | 0.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.3 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.1 | 0.3 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 0.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 0.2 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.1 | 0.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 1.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.2 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.1 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.1 | 0.1 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.1 | 0.1 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.1 | 0.2 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.1 | 0.3 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.1 | 0.3 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.2 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.1 | 0.4 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.1 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.2 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.1 | 0.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.2 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.1 | 0.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 0.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.6 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.4 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 0.2 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.1 | 0.2 | GO:0004040 | amidase activity(GO:0004040) |
0.1 | 0.7 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 1.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 1.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.2 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 1.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.4 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.2 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.1 | 7.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.1 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.1 | 0.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 1.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.1 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.2 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.1 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.2 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 1.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.2 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.1 | 0.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 0.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 2.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.1 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.1 | 0.1 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 1.0 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.2 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.1 | 1.4 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.1 | 0.3 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.1 | 3.0 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 0.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 0.4 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 0.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 1.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 1.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.1 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.0 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.8 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 1.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.0 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 1.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.3 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.3 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.0 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.0 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 0.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 1.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.0 | 0.3 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.0 | 0.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.1 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.0 | 0.1 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.0 | 1.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 1.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 2.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.0 | 0.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.3 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.0 | 1.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.2 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.5 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 0.3 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.1 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.0 | 0.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.3 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 1.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.1 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.0 | 0.1 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
0.0 | 0.2 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.0 | 0.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.0 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 2.6 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
0.0 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.0 | 1.2 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.0 | 0.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.1 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.0 | 0.1 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 1.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.0 | 0.1 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.0 | 0.4 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 1.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.6 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 0.1 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.1 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.0 | 0.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.0 | 0.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.2 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.0 | 0.1 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
0.0 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.2 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 3.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.0 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.1 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.0 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.3 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.0 | 0.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.4 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.0 | 0.1 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.0 | 0.8 | GO:0019001 | guanyl nucleotide binding(GO:0019001) |
0.0 | 0.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.2 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.1 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.0 | 0.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.3 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 3.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.0 | 0.2 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.0 | 0.1 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
0.0 | 0.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 1.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.0 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.3 | GO:0004691 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 1.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.4 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 1.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.1 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.0 | 0.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.1 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.0 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.0 | 0.1 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.0 | 0.1 | GO:0042835 | BRE binding(GO:0042835) |
0.0 | 0.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.0 | 0.1 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 1.6 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 1.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0047708 | biotinidase activity(GO:0047708) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.0 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 0.0 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
0.0 | 0.0 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 1.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 1.0 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.0 | 0.1 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.0 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.0 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.0 | 0.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 1.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.0 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.0 | 0.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 2.7 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.1 | GO:0015165 | nucleotide-sugar transmembrane transporter activity(GO:0005338) pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 3.8 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.1 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.0 | 0.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.1 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.0 | GO:1990446 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 1.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.3 | GO:0009975 | guanylate cyclase activity(GO:0004383) cyclase activity(GO:0009975) |
0.0 | 0.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.0 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.0 | 0.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.0 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.0 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 2.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.0 | GO:0052827 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol pentakisphosphate phosphatase activity(GO:0052827) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
0.0 | 0.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.0 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.0 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.0 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.0 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.0 | 0.0 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 10.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.3 | 2.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 6.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 5.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 4.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 9.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 2.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 2.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 3.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 3.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 4.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 4.0 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 2.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 1.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 2.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 2.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 1.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 1.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 2.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 1.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 1.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 1.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 9.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.5 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 1.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 1.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 1.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.6 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 2.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 1.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 3.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 8.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 8.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 5.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 4.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 2.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 6.9 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.2 | 8.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 6.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 0.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 4.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 0.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 0.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 10.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 4.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 3.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 3.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 2.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 4.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 2.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 0.8 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 10.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 2.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 3.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 2.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.5 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 3.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 2.0 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 2.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 2.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 0.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 1.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 2.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 2.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 2.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 1.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.5 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 4.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 1.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 3.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.5 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 2.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.4 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.4 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 0.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 2.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 1.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 1.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 1.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 1.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 1.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 2.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 1.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.6 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 1.4 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 1.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.6 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 0.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.2 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 1.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.5 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.2 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 1.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 2.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 1.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION | Genes involved in TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation |
0.0 | 0.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 1.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |